313 related articles for article (PubMed ID: 17001771)
1. Haemostasis.
Arnout J; Hoylaerts MF; Lijnen HR
Handb Exp Pharmacol; 2006; (176 Pt 2):1-41. PubMed ID: 17001771
[TBL] [Abstract][Full Text] [Related]
2. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
3. The hemostatic system.
Stassen JM; Arnout J; Deckmyn H
Curr Med Chem; 2004 Sep; 11(17):2245-60. PubMed ID: 15379710
[TBL] [Abstract][Full Text] [Related]
4. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
5. [Endothelial cells and vascular hemostasis].
Levin EG; Hanano M
Nihon Rinsho; 1992 Feb; 50(2):303-6. PubMed ID: 1319512
[TBL] [Abstract][Full Text] [Related]
6. An overview of hemostasis.
Troy GC
Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):5-20. PubMed ID: 3282384
[TBL] [Abstract][Full Text] [Related]
7. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
de Haan J; van Oeveren W
Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of thrombus formation and lysis.
Stump DC; Mann KG
Ann Emerg Med; 1988 Nov; 17(11):1138-47. PubMed ID: 3142314
[TBL] [Abstract][Full Text] [Related]
9. [Dysfunction of fibrinolysis as a risk factor of thrombosis].
Kołodziejczyk J; Wachowicz B
Pol Merkur Lekarski; 2009 Oct; 27(160):341-5. PubMed ID: 19928667
[TBL] [Abstract][Full Text] [Related]
10. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.
Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Burra P; Angeli P; Senzolo M; Simioni P
JHEP Rep; 2022 Jul; 4(7):100493. PubMed ID: 35647501
[TBL] [Abstract][Full Text] [Related]
11. Formation and regulation of platelet and fibrin hemostatic plug.
Hawiger J
Hum Pathol; 1987 Feb; 18(2):111-22. PubMed ID: 3804319
[TBL] [Abstract][Full Text] [Related]
12. Interplay between platelets and coagulation.
Sang Y; Roest M; de Laat B; de Groot PG; Huskens D
Blood Rev; 2021 Mar; 46():100733. PubMed ID: 32682574
[TBL] [Abstract][Full Text] [Related]
13. Physiology of blood coagulation.
Bloom AL
Haemostasis; 1990; 20 Suppl 1():14-29. PubMed ID: 2083865
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
15. Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders.
Pezeshkpoor B; Oldenburg J; Pavlova A
Hamostaseologie; 2022 Oct; 42(S 01):S5-S12. PubMed ID: 35226963
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
Matsumoto T; Nogami K; Shima M
Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
[TBL] [Abstract][Full Text] [Related]
17. Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.
Bode C; Meinhardt G; Runge MS; Freitag M; Nordt T; Arens M; Newell JB; Kübler W; Haber E
Circulation; 1991 Aug; 84(2):805-13. PubMed ID: 1860223
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding.
Ewenstein BM
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 2):770-7. PubMed ID: 8828560
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and fibrinolysis.
Nilsson IM
Scand J Gastroenterol Suppl; 1987; 137():11-8. PubMed ID: 3321400
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
